Febuxostat XR

DRUG4 trials

Sponsors

Takeda

Conditions

GoutHealthy VolunteersModerate Renal Impairment

Phase 1

Food Effect Study of Febuxostat XR in Healthy Participants

CompletedNCT02374164

Start: 2015-02-28End: 2015-04-30Updated: 2016-04-27

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule

CompletedNCT02382640

TakedaHealthy Volunteers

Start: 2015-03-31End: 2015-05-31Updated: 2016-04-29

Phase 2

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

CompletedNCT02128490

TakedaGout, Moderate Renal Impairment

Start: 2014-05-31End: 2015-10-31Updated: 2016-11-03

Phase 3

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout

CompletedNCT02139046

Start: 2014-04-30End: 2015-11-30Updated: 2016-11-03

Related Papers

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.

2018-05-3016 citations